FEDERATED HERMES, INC. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,894,519
-42.9%
901,509
-12.8%
0.01%
-41.2%
Q2 2023$6,816,222
-3.9%
1,034,328
-1.0%
0.02%
-5.6%
Q1 2023$7,094,036
+19.4%
1,044,777
+30.0%
0.02%
+12.5%
Q4 2022$5,940,954
+21.8%
803,918
+62.8%
0.02%
+14.3%
Q3 2022$4,879,000
-7.8%
493,845
+1.8%
0.01%0.0%
Q2 2022$5,289,000
-13.2%
485,281
-9.9%
0.01%0.0%
Q1 2022$6,091,000
-28.5%
538,542
-0.8%
0.01%
-12.5%
Q4 2021$8,514,000
-9.3%
542,664
-1.0%
0.02%
-11.1%
Q3 2021$9,391,000
-14.8%
547,892
+6.9%
0.02%
-14.3%
Q2 2021$11,028,000
+45.2%
512,667
+1.4%
0.02%
+40.0%
Q1 2021$7,595,000
+24.4%
505,631
+8.8%
0.02%
+25.0%
Q4 2020$6,104,000
+36.8%
464,525
+0.5%
0.01%
+20.0%
Q3 2020$4,463,000
+51.1%
462,010
+79.0%
0.01%
+42.9%
Q2 2020$2,953,000
+17.3%
258,137
+6.2%
0.01%0.0%
Q1 2020$2,518,000
+47.4%
243,070
+133.5%
0.01%
+75.0%
Q4 2019$1,708,000
-72.5%
104,097
-77.7%
0.00%
-73.3%
Q3 2019$6,201,000
+88.7%
466,907
+100.2%
0.02%
+87.5%
Q2 2019$3,286,000
-30.0%
233,227
-8.6%
0.01%
-33.3%
Q1 2019$4,693,000
+34.0%
255,094
+90.3%
0.01%
+20.0%
Q4 2018$3,503,000
+18336.8%
134,056
+16826.3%
0.01%
Q3 2018$19,000
-95.8%
792
-96.8%
0.00%
-100.0%
Q3 2017$450,000
-60.2%
25,131
-64.6%
0.00%
-66.7%
Q4 2016$1,132,000
+1055.1%
70,961
+1102.3%
0.00%
Q3 2016$98,000
-31.9%
5,902
-61.9%
0.00%
Q1 2015$144,000
+12.5%
15,500
+73.9%
0.00%
Q4 2014$128,0008,9150.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders